Epitel, Inc.
PrivateLast Round
Series A
Feb 16, 2022
Total Funding Raised
$20M
Company Overview
Epitel, Inc. is a digital health company that develops and commercializes wearable, wireless electroencephalogram (EEG) monitoring technology for seizure detection. Its main product, the REMI Remote EEG Monitoring System, is an FDA-cleared platform designed to provide accessible, affordable, and reliable electrographic seizure detection in various healthcare settings, including hospitals, emergency rooms, and at home. The company leverages a proprietary cloud-based wearable sensor system and artificial intelligence to empower clinicians with better data for treatment decisions. Founded in 2007 and headquartered in Salt Lake City, Utah, Epitel is a venture-backed company that has raised a $12.5 million Series A financing round to support commercialization and further development.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epitel, Inc. Comps
Public and private peers based on sector, stage, and business model.
Epitel, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 16, 2022 | ||||
| Grant | Feb 15, 2022 | ||||
| Seed | Dec 16, 2019 |
Key People
Founding team and executive leadership
Epitel, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ideaship | Seed |
| NIH RADx | Grant |
| OSF Ventures | Series A |
| Dexcom Ventures | Series A |
| Genoa Ventures | Series A |
| Wavemaker Three-Sixty Health | Series A |
| Epilepsy Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2025
Developing REMI portfolio, an AI-enabled seizure monitoring platform.
- Feb 13, 2025
Steve Pacelli named new Chief Executive Officer.
Epitel, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epitel, Inc.'s valuation, stock price, and market status.
